차입 증가 → 이자부담 → 수익성 악화
Critical부채가 +124.7% 늘며 이자보상배율이 287.7x에서 124.1x로 하락했다. ROE도 9.7%에서 5.1%로 낮아져 차입 부담이 수익성을 누르고 있다.
Evidence
부채 YoY +124.7%이자보상배율 287.7x→124.1xROE 9.7%→5.1%
Sukgyung AT
A357550 · KOSDAQ₩34,450+8.85%
2026-08-03 closeSukgyung AT — pricey right now, or cheap? And what signals are flashing today?
Open the exact grade & valuation bands with Pro →Loading chart…
Close
AI Insight
Why these signals fired — only backtest-proven edge, told honestly
Strong-buy signal — the real recordrecord · not a prediction
Not this one stock, but every strong-buy pick we actually published (Korea market). When this stock flashes the signal, it is treated by the same rule.(as of 2026-08-03)
Last 30 sessions
648 picks
Next-day win rate
49.2%
Avg next-day
-0.17%
vs market
+0.72%p
Beat the market on 62.1% of picks (each pick vs its own day’s market average).
Recent publish days (next-day win rate)
07-31 0%07-30 66.7%07-29 0%07-28 45%07-27 20%07-25 36.4%07-21 55.6%07-20 53.8%07-16 53.3%07-15 50%07-14 71.4%07-13 31.2%
This stock has not flashed this signal recently — the record above is the signal’s own, not this stock’s.
Entry is the latest close at publish time; next-day is the following close. “Market” is the equal-weighted average of every stock in the same market that day; delisted names are excluded from both. Fees, taxes and slippage are not included. An observed record over a short window, not a pre-registered backtest. Not investment advice.
Valuation Grades
Relative to 110 화학 peers · not investment advice
Valuation in its own history
PER 43.34 · PBR 4.72 — own history (2020-12~) percentiles 84/100 · 84/100
PER84/100
PBR84/100
Higher indicates lower valuation relative to its history (based on earnings and book yields).
Earnings percentiles can fluctuate for cyclical companies (including loss periods), so the book basis is shown alongside. Companies with large share buybacks can have structurally high PBR. Factual information, not investment advice.
Financial safety
Reference indicatorAs of 2024Safe zoneFinancial-metric reference signal
Altman Z'' zoneZ'' 8.56
Distress
Grey
Safe
- Altman Z''
- 8.56
- Beneish M-Score
- -2.31
- Sloan accrual
- -0.12%
No statistical flag
부실·조작 위험을 나타내는 사실 지표입니다. 투자 조언이 아니며, 검증 전이라 참고용입니다.
Factual information, not investment advice.
Why has this company moved this way?
Auditable observations with the original numeric evidence.
Factual information, not investment advice.
Earnings quality · Piotroski F-Score
4/9Moderate
Piotroski measures year-over-year financial improvement, not absolute quality.
Financial improvement score4/9
Profitability
- Positive ROAPass
- Positive OCFPass
- Improving ΔROAPass
- Accruals (OCF > net income)Pass
Leverage & liquidity
- Lower debtNot passed
- Higher current ratioNot passed
- No new sharesNot passed
Efficiency
- Higher gross marginNot passed
- Higher asset turnoverNot passed
Calculation note: F7(신주)은 equity/asset 유지로 근사
Already-stable companies may score lower when year-over-year improvement is limited.
Factual information, not investment advice.
Forensic signals
Anomaly and structural signals observed in the financial statements.
Balance sheetWarning
부채총계 급증 (+125%). 통계적 정황 신호이며 회계부정 단정이 아닙니다.
Margin trendWarning
영업이익률 악화 (28.7% → 14.6%, -14.1%p). 통계적 정황 신호이며 회계부정 단정이 아닙니다.
Margin trendWarning
영업외손익 급변 (영업이익 대비 117% 규모 변동) — 일회성 손익 주의. 통계적 정황 신호이며 회계부정 단정이 아닙니다.
Factual information, not investment advice.
Industry structure
KRAs of 2026-08-03화학
This stock is in 화학: revenue rank 106 of 109, share 0%.
106 / 1090%revenue share
Who dominates this industry?
- 1LG화학31.9%
- 2롯데케미칼13.3%
- 3금호석유화학4.7%
- 4DL3.7%
- 5코오롱인더3.2%
- 6석경에이티0%
Concentration
DistributedCR3 49.9%HHI and CR3 are separate industrial-organization facts; they are not the polarization verdict.
Polarization
MixedConsistentPolarization measures industry gaps and structure, not valuation, forecast, or investment advice.
Margin lens
- IQR%p
- 8.66
- Direction
- 확대
- Level
- 보통
- Years
- 6
Value lens
- P90/P10
- 9.3
- Median P/B
- 0.71
- Level
- 넓음
- n
- 98
Survivorship note: 현재 산업 멤버십을 과거 연도에 소급 적용 — 과거 진입·퇴출 기업 미반영(복원 불가)
Factual information, not investment advice.
Risk sensitivity — adverse assumptions
Metric changes under stated assumptions; not a forecast or investment advice.
Base metrics
- Operating margin
- 14.6%
- Interest coverage
- 124.1x
- Return on equity (ROE)
- 10.9%
Operating margin −5pp
TolerableInterest coverageBase 124.1x adverse case 81.7x
Return on equity (ROE)Base 10.9% adverse case 3.3%
Revenue −15%
TolerableInterest coverageBase 124.1x adverse case 105.5x
Return on equity (ROE)Base 10.9% adverse case 4.3%
Interest rate +2pp
TolerableInterest coverageBase 124.1x adverse case 9.9x
Return on equity (ROE)Base 10.9% adverse case 4.6%
Interest coverage limit
Current margin 14.5ppInterest coverage limit at an operating margin of 0.1%
Interest expense coverage threshold
Key suppliers · Annual report
Annual reportDART · 2026-03-18Suppliers disclosed by the company in its 2026-03-18 annual report.
Suppliers without disclosed amount
YtterbiumEthanolYtterbiumtrioxideIMCTTOYOTATSUSHOMATERIALYtterbiumFluorideYbFSiOSeriesSilicaBarium+6 more
Financials at a glance
Sukgyung AT's latest results and balance sheet. The bars track the last three periods.
Who held it · filings
Filed recordA historical record from curated-guru 13F filings and DART 5%+ major-holding disclosures.
US 13F는 분기 공시이며 최대 45일 뒤 제출될 수 있습니다.
5%+ major-holding disclosures
- 임형섭39.74%2026-06-22 · 증감 -1.09%p
Recent filings
Sukgyung AT's latest filings on Korea's DART. Open a headline for a reference summary and the original.
Source: DART (Korea electronic disclosure)
Like these rules? Run them automatically.
Quantus turns rules like these into backtests and automated trading — same team, free to start.
Quantus Signal · live data · not investment advice · Privacy Policy